Group | Normoxia | Hypoxia |
---|
 | +Insulin | -Insulin | +Insulin | -Insulin |
---|
VC | 0.32±0.11 | 0.07±0.04 | 0.79±0.15* | 0.08±0.05 |
WT-IRS-1 | 0.34±0.08 | 0.09±0.06 | 0.82±0.13* | 0.10±0.05 |
Arg972-IRS-1 | 0.27±0.10 | 0.05±0.03 | 0.38±0.08a,b,c | 0.06±0.03 |
VC+LY | 0.06±0.04 | 0.04±0.02 | 0.09±0.05a,b,c,d | 0.04±0.02 |
SC | 0.30±0.12 | 0.06±0.03 | 0.80±0.13* | 0.07±0.04 |
IRS-1-shRNA | 0.08±0.05 | 0.04±0.02 | 0.11±0.06a,b,c,d | 0.06±0.03 |
- Note: Human cardiomyocytes were stably transfected with wild type (WT) IRS-1 or Arg972 IRS-1, or stably transduced with IRS-1-shRNA. Then the cells were cultured under normoxia or hypoxia for 24 hours in the presence or absence of LY294002 (LY, 50 μM) or insulin (1 mg/L). Human cardiomyocytes stably transfected with empty pcDNA3.1 plasmids was used as a control (VC). *p<0.05 compared with any group under normoxia; ap<0.05 compared with VC or SC under hypoxia+insulin (1 mg/L); bp<0.05 compared with WT-IRS-1 under hypoxia+insulin (1 mg/L); cp<0.05 compared with Arg972-IRS-1 under normoxia+insulin (1 mg/L); dp<0.05 compared with Arg972-IRS-1 under hypoxia+insulin (1 mg/L).